Reaction

Performance Enhancing Product Use reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 93 reports · 2 co-occurring drugs

As of the last recalculation, Performance Enhancing Product Use appears in 93 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is TESTOSTERONE (PRR 309.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Testosterone24309.3309.7
Anastrozole Tablets20265.5265.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.